Whales with a great deal of cash to invest have actually taken a visibly bullish position on Novo Nordisk
Taking a look at alternatives history for Novo Nordisk (NYSE: NVO) we discovered 16 trades.
If we think about the specifics of each trade, it is precise to state that 68% of the financiers opened trades with bullish expectations and 18% with bearish.
From the general spotted trades, 5 are puts, for an overall quantity of $1,143,389 and 11, calls, for an overall quantity of $695,418.
Projected Cost Targets
Considering the Volume and Open Interest on these agreements, it appears that whales have actually been targeting a rate variety from $40.0 to $60.0 for Novo Nordisk over the last 3 months.
Volume & & Open Interest Trends
Taking a look at the volume and open interest is an informative method to carry out due diligence on a stock.
This information can assist you track the liquidity and interest for Novo Nordisk’s alternatives for a provided strike cost.
Listed below, we can observe the development of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk’s whale activity within a strike cost variety from $40.0 to $60.0 in the last thirty days.
Novo Nordisk Choice Activity Analysis: Last 1 month
Greatest Options Identified:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Cost | Strike Cost | Overall Trade Cost | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | PUT | TRADE | BULLISH | 12/17/27 | $ 12.1 | $ 11.6 | $ 11.6 | $ 55.00 | $ 928.0 K | 383 | 0 |
| NVO | CALL | SWEEP | BULLISH | 11/07/25 | $ 2.79 | $ 2.4 | $ 2.4 | $ 58.00 | $ 120.0 K | 219 | 501 |
| NVO | CALL | SWEEP | BULLISH | 01/15/27 | $ 14.2 | $ 13.9 | $ 14.2 | $ 50.00 | $ 116.4 K | 5.7 K | 83 |
| NVO | CALL | SWEEP | BEARISH | 11/21/25 | $ 2.33 | $ 2.32 | $ 2.33 | $ 60.00 | $ 92.2 K | 16.2 K | 716 |
| NVO | CALL | SWEEP | BULLISH | 11/21/25 | $ 4.25 | $ 4.15 | $ 4.25 | $ 55.00 | $ 85.0 K | 6.0 K | 253 |
About Novo Nordisk
With approximately one-third of the international top quality diabetes treatment market, Novo Nordisk is the leading service provider of diabetes care items on the planet. Based in Denmark, the business makes and markets a range of human and contemporary insulins, injectable diabetes treatments such as GLP-1 treatment, oral antidiabetic representatives, and weight problems treatments. Novo likewise has a biopharmaceutical sector (contributing less than 10% of income) that focuses on protein treatments for hemophilia and other conditions.
Having actually analyzed the alternatives trading patterns of Novo Nordisk, our attention now turns straight to the business. This shift permits us to explore its present market position and efficiency
Where Is Novo Nordisk Standing Today?
- With a volume of 1,321,073, the cost of NVO is up 1.93% at $55.42.
- RSI indications hint that the underlying stock is presently neutral in between overbought and oversold.
- Next incomes are anticipated to be launched in 16 days.
Professional Viewpoints on Novo Nordisk
In the last month, 3 specialists launched rankings on this stock with a typical target cost of $57.33.
Unusual Options Activity Detected: Smart Cash on the Move
Benzinga Edge’s Unusual Options board areas prospective market movers before they occur. See what positions huge cash is handling your preferred stocks. Click on this link for gain access to
* An expert from HSBC updated its action to Purchase with a rate target of $70.
* An expert from Morgan Stanley has actually modified its score downward to Underweight, changing the cost target to $47.
* Constant in their examination, an expert from BMO Capital keeps a Market Perform score on Novo Nordisk with a target cost of $55.
Options trading provides greater dangers and prospective benefits. Astute traders handle these dangers by constantly informing themselves, adjusting their methods, keeping track of numerous indications, and keeping a close eye on market motions. Stay notified about the most recent Novo Nordisk alternatives trades with real-time notifies from Benzinga Pro.